Odyssey Health, Inc. (ODYY)
Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies. Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Odyssey Health, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
USOdyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products.
Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies.
Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.
Leadership
Jeffrey Conroy
Director
Jerome H. Casey
Director
John P. Gandolfo
Director
Joseph Michael Redmond
Chairman, President & Chief Executive Officer
Employees
4
Country
US
Sector
Healthcare
Website
odysseyhealthinc.com
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
US30d Avg
44.30K
60d Avg
199.57K
90d Avg
196.07K